INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of September 15, 2025 Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. (CAPR) Class Action – Investors With Significant Losses Encouraged to Contact the Firm

Core Viewpoint - A shareholder class action lawsuit has been filed against Capricor Therapeutics, Inc. alleging that the company made materially false and misleading statements regarding the safety and efficacy data from its Phase 2 HOPE-2 trial study of deramiocel [1] Group 1 - The lawsuit claims that Capricor failed to disclose material adverse information concerning its four-year safety and efficacy data [1] - The lawsuit specifically targets shareholders who purchased shares between October 9, 2024, and July 10, 2025, and experienced significant losses [2] - The deadline for shareholders to request to be appointed as lead plaintiff in the case is September 15, 2025 [3] Group 2 - Holzer & Holzer, LLC is representing the shareholders in this litigation and has a history of recovering hundreds of millions of dollars for shareholders affected by corporate misconduct [3] - The firm has been recognized as an ISS top-rated securities litigation law firm for the years 2021, 2022, and 2023 [3] - Contact information for the law firm is provided for shareholders seeking to discuss their legal rights [4]